Search results
6 days ago · Our broad portfolio of approximately 280+ generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets.
Together, we can do more to improve health. That’s a powerful reason to come to work. In addition to being guided by a deep sense of purpose, we’re also focused on rapidly growing our capabilities, our product portfolios and our people – all to increase the number of lives we can touch.
Get the latest Amneal Pharmaceuticals Inc (AMRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Find the latest Amneal Pharmaceuticals, Inc. (AMRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines.
Amneal is a global, diversified pharmaceutical company that provides access to high-quality, affordable, and essential medicines. Press Releases Stock Information
May 27, 2022 · Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals, primarily within the United States.
Our broad portfolio of approximately 270 generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.
